Enzalutamide Suppliers & Bulk Manufacturers
Available Forms: Tablet & Capsule
Available Strengths: Capsules- 40 mg, Tablet - 40 mg & 80 mg
Reference Brands: Xtandi® (EU & US)
Category: Oncology Cancer Care
Enzalutamide is an oral androgen receptor inhibitor used in treating advanced prostate cancer, available in 40 mg capsules and 40/80 mg tablets in the US and EU under the brand name Xtandi®..
Product Description: Enzalutamide is a next-generation androgen receptor inhibitor indicated for the treatment of prostate cancer, including metastatic castration-resistant and non-metastatic castration-resistant forms. Marketed as Xtandi®, it is available in 40 mg capsules and 40 mg/80 mg tablets in both the US and EU. It works by blocking androgen signaling pathways, helping slow disease progression. With proven clinical benefits and oral administration, Enzalutamide represents a high-value B2B oncology opportunity for pharmaceutical partners targeting the oncology segment in regulated markets such as the EU and United States.
Enzalutamide — third party manufacturing & bulk supply
Enzalutamide is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Enzalutamide is supplied as Tablet & Capsule — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Enzalutamide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Enzalutamide →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
